Artificial intelligence rapidly becomes an integral part of healthcare delivery, offering capabilities that extend from administrative automation to predictive analytics and diagnostic support. The American Medical Association (AMA) refers to these technologies as augmented intelligence to emphasise their role in enhancing rather than replacing human expertise. According to the AMA’s 2024 survey, physicians are already using AI in areas such as documentation, diagnosis assistance, translation services and workflow planning. The benefits include increased efficiency, reduced burden on clinicians and improved accuracy in patient care. However, risks remain, including bias, privacy concerns, liability and the danger of incorrect or misleading outputs. These opportunities and risks highlight the importance of effective governance structures. The AMA has developed a toolkit that provides healthcare organisations with structured guidance on how to establish governance frameworks to manage, evaluate and scale AI solutions responsibly. 

Leadership and Strategic Oversight 

The AMA stresses that leadership commitment is critical for successful AI integration. Executive-level accountability ensures that AI initiatives are prioritised, resourced and aligned with organisational strategy. Chief executives play a central role in communicating AI’s potential benefits while articulating both short-term goals and longer-term ambitions. Some health systems integrate AI governance within existing technology committees, while others establish dedicated AI committees to provide focused oversight. In both models, executive leaders such as chief medical officers, chief nursing officers, chief information officers and legal advisors are typically involved. Decisions may also include whether to appoint a chief AI officer or distribute responsibilities across existing roles. Interdisciplinary working groups are often formed to define priorities, develop policies and outline governance processes. These groups may evolve into permanent governance committees or transition oversight responsibilities once policies and structures are embedded. The aim is to ensure clarity, accountability and alignment across clinical, operational and strategic domains. 

Must Read: A Framework for Responsible AI in Healthcare 

Policy Development and Risk Mitigation 

Strong governance requires clear policies to manage the challenges posed by AI. The AMA identifies several areas of concern that healthcare organisations must address. Bias in datasets and algorithms can reinforce disparities, while limited explainability and transparency can undermine trust and safety. Liability questions remain unsettled, raising uncertainty over responsibility when AI recommendations influence patient care. Data privacy and security add another layer of complexity, particularly with the growing use of generative AI and the risks of re-identification or malicious data manipulation. Governance frameworks should establish policies that define permitted and prohibited uses of AI, articulate accountability mechanisms and ensure regulatory compliance. Transparency is also essential, with guidelines to inform patients when AI has contributed to their care. Policies should integrate with existing frameworks, including those on antidiscrimination, patient safety and data use. Standardised project intake and vendor evaluation processes provide consistency, prevent duplication and allow careful assessment of risks, benefits and resource requirements. By embedding risk management into policy and oversight structures, organisations can protect both patients and clinicians while enabling innovation. 

Implementation, Monitoring and Organisational Readiness 

The AMA’s guidance highlights that successful governance extends beyond policy into practical implementation and monitoring. Standard planning and project management processes should be adapted to reflect AI-specific considerations such as bias testing, validation and workflow integration. Pilots in defined settings allow organisations to assess effectiveness, safety and efficiency before large-scale adoption. Continuous oversight is essential, with monitoring processes designed to track performance, detect bias and identify data or concept drift that could compromise outputs. Multidisciplinary monitoring teams, including clinical leaders, data scientists and administrative representatives, are recommended to ensure accountability and responsiveness. Audits, feedback loops and clear communication channels with both clinicians and patients are part of this approach. Organisational readiness also requires active engagement across departments. Training must be updated to include AI use and associated risks, procurement processes should account for AI-specific vendor requirements and communications teams should prepare to address public and patient inquiries. By embedding these activities into governance, healthcare systems can adapt effectively as new AI tools emerge while maintaining trust and safety. 

The AMA’s governance framework underlines that the safe and effective adoption of AI in healthcare depends on leadership, policy, oversight and readiness. Augmented intelligence can enhance diagnostic accuracy, support workforce sustainability, improve patient experience and accelerate biomedical advances. Yet these benefits are inseparable from the risks of bias, privacy breaches, liability uncertainty and potential misuse. Governance provides the structures needed to manage these risks while enabling innovation. By following structured guidance and engaging stakeholders across clinical, operational, legal and technological domains, healthcare organisations can scale AI responsibly. Governance must remain iterative and adaptive to new technologies, ensuring that augmented intelligence serves as a tool to support equitable, safe and patient-centred care. 

Source: American Medical Association 

Image Credit: iStock